The Novel Nrf2 Agonist Neobavaisoflavone Attenuates Periodontitis by Inhibiting Osteoclastogenesis through Iron Homeostasis Regulation and Senescence Suppression
The Novel Nrf2 Agonist Neobavaisoflavone Attenuates Periodontitis by Inhibiting Osteoclastogenesis through Iron Homeostasis Regulation and Senescence Suppression Overall design: In this experiment, we induce RAW264.7 cells to differentiate into osteoclasts. The experimental group is treated with 8 µM neobavaisoflavone, while the control group receives an equal volume of the solvent DMSO. Our aim is to investigate the potential mechanism by which neobavaisoflavone exerts an inhibitory effect on osteoclast differentiation.